{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-22-017649","form_type":"8-K","ticker":"NUS","cik":"0001021561","company_name":"NU SKIN ENTERPRISES, INC.","filed_at":"2022-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.351414+00:00","generated_at":"2026-06-26T00:19:10.708044+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Nu Skin Q1 revenue $604.9M (-11% YoY), EPS $0.76 (-16%); lowers FY22 guidance","bullets":["Revenue $604.9M, down 11% YoY; EPS $0.76 vs $0.91; gross margin 73.3% vs 74.8%.","Customers fell 13% to 1.32M; paid affiliates -14%; sales leaders -22%.","Q2 revenue guidance $590-620M (down 12-16%); EPS $0.75-0.85 (down 26-35%).","Full-year 2022 revenue guidance cut to $2.51-2.62B (down 3-7%); EPS $3.60-3.90.","Declines blamed on COVID lockdowns in China, Ukraine/Russia conflict, FX headwinds."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-22-017649","json":"https://secwatch.observer/filing/0001140361-22-017649.json","markdown":"https://secwatch.observer/filing/0001140361-22-017649.md","text":"https://secwatch.observer/filing/0001140361-22-017649.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1021561/000114036122017649/0001140361-22-017649-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1021561/000114036122017649/brhc10037177_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T00:19:10.708044+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}